Literature DB >> 32860515

Baseline and innate immune response characterization of a Zfp30 knockout mouse strain.

Lucas T Laudermilk1,2, Adelaide Tovar1,2, Alison K Homstad1,2, Joseph M Thomas1, Kathryn M McFadden1, Miriya K Tune3, Dale O Cowley1,4, Jason R Mock3, Folami Ideraabdullah1,2,5, Samir N P Kelada6,7,8.   

Abstract

Airway neutrophilia is correlated with disease severity in a number of chronic and acute pulmonary diseases, and dysregulation of neutrophil chemotaxis can lead to host tissue damage. The gene Zfp30 was previously identified as a candidate regulator of neutrophil recruitment to the lungs and secretion of CXCL1, a potent neutrophil chemokine, in a genome-wide mapping study using the Collaborative Cross. ZFP30 is a putative transcriptional repressor with a KRAB domain capable of inducing heterochromatin formation. Using a CRISPR-mediated knockout mouse model, we investigated the role that Zfp30 plays in recruitment of neutrophils to the lung using models of allergic airway disease and acute lung injury. We found that the Zfp30 null allele did not affect CXCL1 secretion or neutrophil recruitment to the lungs in response to various innate immune stimuli. Intriguingly, despite the lack of neutrophil phenotype, we found there was a significant reduction in the proportion of live Zfp30 homozygous female mutant mice produced from heterozygous matings. This deviation from the expected Mendelian ratios implicates Zfp30 in fertility or embryonic development. Overall, our results indicate that Zfp30 is an essential gene but does not influence neutrophilic inflammation in this particular knockout model.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32860515      PMCID: PMC7486244          DOI: 10.1007/s00335-020-09847-z

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   3.224


  40 in total

1.  A major locus conferring susceptibility to infection by Streptococcus pneumoniae in mice.

Authors:  Paul Denny; Elaine Hopes; Neill Gingles; Karl W Broman; William McPheat; John Morten; Janet Alexander; Peter W Andrew; Steve D M Brown
Journal:  Mamm Genome       Date:  2003-07       Impact factor: 2.957

2.  The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD.

Authors:  A M Kirsten; K Förster; E Radeczky; A Linnhoff; B Balint; H Watz; H Wray; L Salkeld; M Cullberg; B Larsson
Journal:  Pulm Pharmacol Ther       Date:  2015-02-11       Impact factor: 3.410

3.  Mapping lipopolysaccharide response loci in mice using recombinant inbred and congenic strains.

Authors:  L E Matesic; A De Maio; R H Reeves
Journal:  Genomics       Date:  1999-11-15       Impact factor: 5.736

4.  KAP-1 corepressor protein interacts and colocalizes with heterochromatic and euchromatic HP1 proteins: a potential role for Krüppel-associated box-zinc finger proteins in heterochromatin-mediated gene silencing.

Authors:  R F Ryan; D C Schultz; K Ayyanathan; P B Singh; J R Friedman; W J Fredericks; F J Rauscher
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

5.  Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis.

Authors:  Richard B Moss; Sunil J Mistry; Michael W Konstan; Joseph M Pilewski; Eitan Kerem; Ruth Tal-Singer; Aili L Lazaar
Journal:  J Cyst Fibros       Date:  2012-09-17       Impact factor: 5.482

6.  Nlrp12 mutation causes C57BL/6J strain-specific defect in neutrophil recruitment.

Authors:  Tyler K Ulland; Nidhi Jain; Emma E Hornick; Eric I Elliott; Gwendolyn M Clay; Jeffrey J Sadler; Kathleen A M Mills; Ann M Janowski; A Paige Davis Volk; Kai Wang; Kevin L Legge; Lokesh Gakhar; Mohammed Bourdi; Polly J Ferguson; Mary E Wilson; Suzanne L Cassel; Fayyaz S Sutterwala
Journal:  Nat Commun       Date:  2016-10-25       Impact factor: 14.919

7.  ZFP30 promotes adipogenesis through the KAP1-mediated activation of a retrotransposon-derived Pparg2 enhancer.

Authors:  Wanze Chen; Petra C Schwalie; Eugenia V Pankevich; Carine Gubelmann; Sunil K Raghav; Riccardo Dainese; Marco Cassano; Michael Imbeault; Suk Min Jang; Julie Russeil; Tenagne Delessa; Julien Duc; Didier Trono; Christian Wolfrum; Bart Deplancke
Journal:  Nat Commun       Date:  2019-04-18       Impact factor: 14.919

Review 8.  KRAB-containing zinc-finger repressor proteins.

Authors:  Raul Urrutia
Journal:  Genome Biol       Date:  2003-09-23       Impact factor: 13.583

9.  High-throughput discovery of novel developmental phenotypes.

Authors:  Mary E Dickinson; Ann M Flenniken; Xiao Ji; Lydia Teboul; Michael D Wong; Jacqueline K White; Terrence F Meehan; Wolfgang J Weninger; Henrik Westerberg; Hibret Adissu; Candice N Baker; Lynette Bower; James M Brown; L Brianna Caddle; Francesco Chiani; Dave Clary; James Cleak; Mark J Daly; James M Denegre; Brendan Doe; Mary E Dolan; Sarah M Edie; Helmut Fuchs; Valerie Gailus-Durner; Antonella Galli; Alessia Gambadoro; Juan Gallegos; Shiying Guo; Neil R Horner; Chih-Wei Hsu; Sara J Johnson; Sowmya Kalaga; Lance C Keith; Louise Lanoue; Thomas N Lawson; Monkol Lek; Manuel Mark; Susan Marschall; Jeremy Mason; Melissa L McElwee; Susan Newbigging; Lauryl M J Nutter; Kevin A Peterson; Ramiro Ramirez-Solis; Douglas J Rowland; Edward Ryder; Kaitlin E Samocha; John R Seavitt; Mohammed Selloum; Zsombor Szoke-Kovacs; Masaru Tamura; Amanda G Trainor; Ilinca Tudose; Shigeharu Wakana; Jonathan Warren; Olivia Wendling; David B West; Leeyean Wong; Atsushi Yoshiki; Daniel G MacArthur; Glauco P Tocchini-Valentini; Xiang Gao; Paul Flicek; Allan Bradley; William C Skarnes; Monica J Justice; Helen E Parkinson; Mark Moore; Sara Wells; Robert E Braun; Karen L Svenson; Martin Hrabe de Angelis; Yann Herault; Tim Mohun; Ann-Marie Mallon; R Mark Henkelman; Steve D M Brown; David J Adams; K C Kent Lloyd; Colin McKerlie; Arthur L Beaudet; Maja Bućan; Stephen A Murray
Journal:  Nature       Date:  2016-09-14       Impact factor: 49.962

10.  Differential Regulation of Zfp30 Expression in Murine Airway Epithelia Through Altered Binding of ZFP148 to rs51434084.

Authors:  Lucas T Laudermilk; Joseph M Thomas; Samir N Kelada
Journal:  G3 (Bethesda)       Date:  2018-02-02       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.